Literature DB >> 18797949

Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology.

Peter Swindle1, Saadallah Ramadan, Peter Stanwell, Simon McCredie, Peter Russell, Carolyn Mountford.   

Abstract

Proton magnetic resonance spectroscopy (MRS) is used to compare the chemistry of the transition, central and peripheral zones of the prostate. The assignments are made using two-dimensional correlated spectroscopy and the results compared with histopathology. The chemistry associated with benign prostatic hyperplasia (BPH), prostate intraepithelial neoplasia (PIN) and malignant biopsy tissues are described. There are distinct MR spectral patterns for glandular and stromal BPH, PIN and adenocarcinoma. Importantly, there are also different spectral patterns from BPH in the transitional and central zones when compared to BPH in the peripheral zone. A pattern recognition method is used to analyze the MR spectra from the biopsy specimens. The resultant mathematical classifiers generated a high level of accuracy (sensitivity and specificity of 100 and 97%). It was found that for this accuracy to be achieved, the classifiers need to be developed by comparing the spectra with specialist serial sectioned histopathology. With serial sectioned pathology the pattern recognition method was capable of identifying less than 5% of adenocarcinoma in a given piece of tissue. Many of the chemicals identified in the biopsy specimens are available for inspection from the prostate, in vivo, at 3 T.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797949     DOI: 10.1007/s10334-008-0136-0

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  42 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra.

Authors:  P Hahn; I C Smith; L Leboldus; C Littman; R L Somorjai; T Bezabeh
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

Review 3.  Proton MRS can determine the pathology of human cancers with a high level of accuracy.

Authors:  Carolyn E Mountford; Sinead Doran; Cynthia L Lean; Peter Russell
Journal:  Chem Rev       Date:  2004-08       Impact factor: 60.622

4.  The anatomic heterogeneity of the prostate.

Authors:  J E McNeal
Journal:  Prog Clin Biol Res       Date:  1980

5.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

6.  The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.

Authors:  C G Ramos; G F Carvahal; D E Mager; B Haberer; W J Catalona
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

7.  Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

Authors:  S Kasper; P C Sheppard; Y Yan; N Pettigrew; A D Borowsky; G S Prins; J G Dodd; M L Duckworth; R J Matusik
Journal:  Lab Invest       Date:  1998-03       Impact factor: 5.662

8.  Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study.

Authors:  J Kurhanewicz; R Dahiya; J M Macdonald; L H Chang; T L James; P Narayan
Journal:  Magn Reson Med       Date:  1993-02       Impact factor: 4.668

9.  The role of increasing detection in the rising incidence of prostate cancer.

Authors:  A L Potosky; B A Miller; P C Albertsen; B S Kramer
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

10.  Malignancy-related characteristics of wild type and drug-resistant Chinese hamster ovary cells.

Authors:  W B Mackinnon; M Dyne; R Hancock; A J Grant; P Russell; C E Mountford
Journal:  Pathology       Date:  1993-07       Impact factor: 5.306

View more
  5 in total

1.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

2.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.

Authors:  Satish E Viswanath; Nicholas B Bloch; Jonathan C Chappelow; Robert Toth; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2012-02-15       Impact factor: 4.813

3.  H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples.

Authors:  Katarina Stenman; Pär Stattin; Hans Stenlund; Katrine Riklund; Gerhard Gröbner; Anders Bergh
Journal:  Biomark Insights       Date:  2011-03-14

4.  MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils.

Authors:  Rajakumar Nagarajan; Daniel Ja Margolis; Steven S Raman; David Ouellette; Manoj K Sarma; Robert E Reiter; M Albert Thomas
Journal:  Magn Reson Insights       Date:  2013-05-15

Review 5.  MRS-based Metabolomics in Cancer Research.

Authors:  Tedros Bezabeh; Omkar B Ijare; Alexander E Nikulin; Rajmund L Somorjai; Ian Cp Smith
Journal:  Magn Reson Insights       Date:  2014-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.